Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Gene expression and cancer classification, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, and Genomics and Chromatin Dynamics.
JAG1-NOTCH4 mechanosensing drives atherosclerosis
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
Mining Human Prostate Cancer Datasets: The “camcAPP” Shiny App
Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
Mining human prostate cancer datasets: The “camcAPP” shiny app
Gene regulatory mechanisms underpinning prostate cancer susceptibility
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
HES5 silencing is an early and recurrent change in prostate tumourigenesis
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
935 The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Loss of centrioles causes chromosomal instability in vertebrate somatic cells
Neo-tAnGo science: A translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
Calling Sample Mix-Ups in Cancer Population Studies